Discovery of Novel and Selective DNA Methyltransferase 1 Inhibitors by Pharmacophore and Docking‐Based Virtual Screening

[1]  Shagun Krishna,et al.  Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach. , 2017, Journal of molecular graphics & modelling.

[2]  M. Bouhlel,et al.  Rational Design of Bisubstrate-Type Analogues as Inhibitors of DNA Methyltransferases in Cancer Cells. , 2017, Journal of medicinal chemistry.

[3]  T. Baubec,et al.  Dynamics and Context-Dependent Roles of DNA Methylation. , 2017, Journal of molecular biology.

[4]  P. Depreux,et al.  DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge , 2017, Biomolecules.

[5]  M. Amanlou,et al.  A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors. , 2016, Journal of molecular graphics & modelling.

[6]  A. Jeltsch,et al.  Allosteric control of mammalian DNA methyltransferases – a new regulatory paradigm , 2016, Nucleic acids research.

[7]  Anne-Kathrin Garz,et al.  A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers , 2016, Clinical Epigenetics.

[8]  C. Nervi,et al.  Epigenetic treatment of solid tumours: a review of clinical trials , 2015, Clinical Epigenetics.

[9]  M. Adib,et al.  A one-pot, three-component and solvent-free synthesis of 2,3-disubstituted isoindolin-1-ones , 2015 .

[10]  Jikui Song,et al.  Crystal Structure of Human DNA Methyltransferase 1. , 2015, Journal of molecular biology.

[11]  A. Shafiee,et al.  Synthesis of novel 5-arylidene (thio)barbituric acid and evaluation of their urease inhibitory activity , 2015, Journal of the Iranian Chemical Society.

[12]  Margaret A. Goodell,et al.  DNMT3A in haematological malignancies , 2015, Nature Reviews Cancer.

[13]  D. Schübeler.  Function and information content of DNA methylation , 2015, Nature.

[14]  A. Jeltsch,et al.  DNMT1-associated DNA methylation changes in cancer , 2015, Cell cycle.

[15]  C. Brenner,et al.  RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation , 2014, Cell cycle.

[16]  A. Jeltsch,et al.  New concepts in DNA methylation. , 2014, Trends in biochemical sciences.

[17]  J. Medina-Franco,et al.  Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking , 2014, International journal of molecular sciences.

[18]  A. Jeltsch,et al.  Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1. , 2014, Journal of medicinal chemistry.

[19]  S. Anant,et al.  DNA Methyltransferases: A Novel Target for Prevention and Therapy , 2013, Front. Oncol..

[20]  J. Sweatt,et al.  The Emerging Field of Neuroepigenetics , 2013, Neuron.

[21]  P. G. Rao,et al.  Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells , 2013, Molecular Cancer.

[22]  Howard Cedar,et al.  DNA methylation dynamics in health and disease , 2013, Nature Structural &Molecular Biology.

[23]  A. Jeltsch,et al.  Identification of novel inhibitors of DNA methylation by screening of a chemical library. , 2013, ACS chemical biology.

[24]  Oliver Sieber,et al.  Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion , 2013, Molecular Cancer.

[25]  A. Jeltsch,et al.  DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies , 2012, Expert opinion on therapeutic patents.

[26]  M. Mahdavi,et al.  Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffolds , 2012, Journal of Molecular Modeling.

[27]  A. Jeltsch,et al.  Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain. , 2012, Chemistry & biology.

[28]  D. Patel,et al.  Structure-Based Mechanistic Insights into DNMT1-Mediated Maintenance DNA Methylation , 2012, Science.

[29]  A. Jeltsch,et al.  Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide , 2012, Chembiochem : a European journal of chemical biology.

[30]  Min Chen,et al.  DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer , 2011, Molecular Cancer Therapeutics.

[31]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[32]  A. Jeltsch,et al.  C5‐DNA Methyltransferase Inhibitors: From Screening to Effects on Zebrafish Embryo Development , 2011, Chembiochem : a European journal of chemical biology.

[33]  José L. Medina-Franco,et al.  Homology modeling, docking and structure-based pharmacophore of inhibitors of DNA methyltransferase , 2011, J. Comput. Aided Mol. Des..

[34]  E. Yamashita,et al.  Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1) , 2011, Proceedings of the National Academy of Sciences.

[35]  A. Jeltsch,et al.  The inhibition of the mammalian DNA methyltransferase 3a (Dnmt3a) by dietary black tea and coffee polyphenols , 2011, BMC Biochemistry.

[36]  D. Patel,et al.  Structure of DNMT1-DNA Complex Reveals a Role for Autoinhibition in Maintenance DNA Methylation , 2011, Science.

[37]  Youdong Mao,et al.  Characterization of a core fragment of the rhesus monkey TRIM5α protein , 2011, BMC Biochemistry.

[38]  J. Medina-Franco,et al.  Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. , 2010, Bioorganic & medicinal chemistry.

[39]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[40]  Guido Marcucci,et al.  Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide , 2009, Journal of Pharmacology and Experimental Therapeutics.

[41]  Guido Marcucci,et al.  Curcumin is a potent DNA hypomethylation agent. , 2009, Bioorganic & medicinal chemistry letters.

[42]  F. Lyko,et al.  Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine , 2008, International journal of cancer.

[43]  Santosh A. Khedkar,et al.  Pharmacophore modeling in drug discovery and development: an overview. , 2007, Medicinal chemistry (Shariqah (United Arab Emirates)).

[44]  Byron H. Lee,et al.  Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1* , 2005, Journal of Biological Chemistry.

[45]  Frank Lyko,et al.  Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. , 2005, Cancer research.

[46]  P. Jones,et al.  Zebularine: a new drug for epigenetic therapy. , 2004, Biochemical Society transactions.

[47]  A. Jeltsch,et al.  Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy , 2004, Cancer biology & therapy.

[48]  M. Voso,et al.  Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes. , 2004, Blood.

[49]  A. Riggs,et al.  Methylation and epigenetic fidelity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Ni Ai,et al.  Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.

[51]  M. Muller,et al.  Endogenous Assays of DNA Methyltransferases: Evidence for Differential Activities of DNMT1, DNMT2, and DNMT3 in Mammalian Cells In Vivo , 2003, Molecular and Cellular Biology.

[52]  Albert Jeltsch,et al.  Molecular Enzymology of the Catalytic Domains of the Dnmt3a and Dnmt3b DNA Methyltransferases* 210 , 2002, The Journal of Biological Chemistry.

[53]  A. Jeltsch,et al.  Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpA sites 1 1 Edited by J. Karn , 2001 .

[54]  A. Jeltsch,et al.  The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA. , 2001, Journal of molecular biology.

[55]  R J Roberts,et al.  Recombinant Human DNA (Cytosine-5) Methyltransferase , 1999, The Journal of Biological Chemistry.

[56]  E. Li,et al.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.

[57]  R. Blumenthal,et al.  Structure-guided analysis reveals nine sequence motifs conserved among DNA amino-methyltransferases, and suggests a catalytic mechanism for these enzymes. , 1995, Journal of molecular biology.

[58]  R. Jaenisch,et al.  Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[59]  F. Šorm,et al.  5-Azacytidine, a new, highly effective cancerostatic , 1964, Experientia.

[60]  P. Arimondo,et al.  DNA Methyltransferase Inhibitors: Development and Applications. , 2016, Advances in experimental medicine and biology.

[61]  J. Issa,et al.  Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. , 2007, Blood.

[62]  Xiaodong Cheng,et al.  Structure and function of DNA methyltransferases. , 1995, Annual review of biophysics and biomolecular structure.